The HIV-1 Rev protein is a nuclear export factor for unspliced and incompletely-spliced HIV-1 RNAs. 28
Introduction 39
Intron retention is increasingly recognized as a regulatory mechanism of gene expression and 40 diversification of the cellular proteome (1). Transcriptomic analyses indicate that a large percentage of 41 eukaryotic genes encode transcripts retaining introns (2, 3). Intron-retaining transcripts may be trapped 42 in the nucleus leading to their degradation. Alternatively, specialized nuclear export pathways may 43 enable certain intron-retaining transcripts to reach the cytoplasm, where they can be translated or 44 undergo nonsense-mediated decay. Retroviruses use intron retention to encode multiple proteins from 45 one primary transcript. RNA-secondary structures or cellular or viral adaptor proteins link intron-46 retaining retroviral transcripts in the nucleus to the TAP/NXF1 or the CRM-1 nuclear export factors (4), 47 (15). In addition, multiple inhibitory sequences (INS) were identified in the retained introns (16) (17) (18) (19) (20) . The 70 presumed inactivation of these inhibitory sequences by codon-optimizing the AT-rich HIV-1 sequence 71 abolished nuclear retention (21) independent of the presence or absence of HIV-1 splice donor and 72 splice acceptor sites (22, 23) . Why AT-rich intron-containing HIV-1 sequences, but not the codon-73 optimized variants are retained remains elusive. It has been reported that knock-down of the 74 paraspeckle lncRNA NEAT1 could promote HIV Gag production through increased nucleocytoplasmic 75 export of INS-containing RNAs, implicating the nuclear paraspeckles in the nuclear retention of HIV US 76 and IS RNAs (24). However, this has been questioned by a study demonstrating that HIV-1 US RNA was 77 not actually colocalized with paraspeckles (25), despite that several paraspeckle proteins (PSF, Martin3 78 and RBM14) have been reported to associate with HIV-1 INS elements and/or promote the Rev-79 dependent RNA export (26) (27) (28) . 80
In addition to these viral determinants and lncRNA contributing to nuclear mRNA retention, depletion 81 of hnRNPA2/B1 has been shown to increase cytoplasmic levels of HIV-1 genomic RNA, but this 82 increase did not enhance Gag expression levels and the precise mechanism remains unknown (29). 83
With regard to nuclear retention of mRNA in general, a cellular complex named pre-mRNA retention 84 and splicing complex (RES) has been identified in yeast (30). The RES is composed of Bud13, Snu17p, and 85
Pml1P and inactivation of either of these genes in yeast reduces splicing of an intron with a weak 86 5´splice donor. In addition, Pml1P inactivation enhanced expression of a pre-mRNA reporter construct 87 without substantial reduction of the spliced mRNA suggesting a role of Pml1P and the RES in nuclear 88 retention. More recently, BUD13 was identified to bind to the poorly-spliced mRNA of mammalian IRF7, 89 a master regulator of the interferon response (31). Knock-down of BUD13 specifically enhanced 90 retention of intron 4 of IRF7 in stimulated cells thus reducing IRF7 protein levels and dampening the 91 interferon response. However, intron-containing IRF7 mRNA could not be detected in the cytoplasm (31), 92 indicating additional nuclear trapping mechanisms or rapid cytoplasmic degradation of intron-containing 93 IRF7 mRNA. HIV-1 introns also differ from typical RES-dependent introns (31-33) by their low GC 94 content, challenging the hypothesis that HIV-1 splicing may be regulated by the RES. 95 An alternative nuclear trapping mechanism could be a cellular quality control mechanism for mRNAs 96 located at the nuclear pore complex (NPC). Experimental or stress-induced interference with this 97 complex results in leakage of intron-retaining mRNAs into the cytoplasm (34-37). This finding suggests 98 that the NPC-associated quality control complex also has a role in nuclear retention of intron-containing 99 mRNAs, probably as a back-up mechanism not influencing the initial splicing events. Here we identified 100 cellular proteins involved in nuclear trapping of intron-retaining HIV-1 mRNAs by performing a genome-101 wide screen for cellular factors, whose depletion resulted in enhanced expression from HIV-1 unspliced 102 transcripts in the absence of its export factor Rev. Furthermore, we examined the effect of identified 103 cellular factors on HIV US and FS RNAs localization and expression. This revealed that CRNKL1 is a 104 nuclear retention factor of the HIV-1 unspliced RNA and a highly selective regulator of cytoplasmic levels 105 of intron-retaining HIV-1 and cellular mRNAs. 106 components should be maintained. 121
To characterize the expression pattern of HIV-dual-GT, HEK293T cells were transfected with plasmids 122 containing HIV-dual-GT or a rev-deficient env-deletion mutant of HIV in the presence or absence of a 123
Rev-expression plasmid. Western blot analyses revealed Rev-dependent expression of the Gag-BFP 124 fusion protein ( Fig. 1B) . Flow cytometric analysis of HEK293T cells transfected with HIV-dual-GT revealed 125 a major DsRed positive, but BFP negative cell population, that shifted to a double positive population by 126 co-transfection of a Rev-expression plasmid (Fig. 1C ). DsRed expression seemed to decrease in the 127 presence of Rev consistent with reduced splicing and consequently reduced generation of fully-spliced 128
DsRed mRNA due to rapid export of unspliced transcripts (7) . 129 population to a DsRed and BFP double-positive population. The magnitude of this effect was lower than 137 in the co-transfection experiments in 293T cells (Fig. 1C ) consistent with the lower transfection 138 efficiency for Jurkat cells. 139
To obtain more homogenous reporter cells, Jurkat cell clones containing HIV-dual-GT were established 140 by transducing Jurkat cells at an MOI of 0.1, followed by flow cytometric sorting of single DsRed positive, 141 BFP negative cells into wells of a 96-well plate (Fig. 1E) . Two of the expanded DsRed positive cell clones, 142
showing a rather homogenous population of DsRed positive and BPF-negative cells and designated J-143 dual#3 and J-dual#6, were transduced at an MOI of 2 with VSV-G peudotyped env deletion mutants of 144 HIV containing or lacking a functional rev gene. In the presence of a functional rev gene the BFP 145 fluorescence was strongly induced in both reporter cell clones ( Fig. 1F ). Therefore, both clones were 146 selected for the screening for cellular genes that suppress BFP expression from the HIV-dual-GT reporter 147 virus. 148 149 Genome-wide screening for cellular factors suppressing expression from intron-containing HIV-1 150 genomic RNA 151
Poor expression levels of HIV-1 structural genes in the absence of Rev that can be overcome by 152 modifying the codon-usage, suggest that there is an active cellular suppressive mechanism acting on the 153 level of the viral transcript. To identify cellular proteins necessary for this postulated suppressive 154 mechanism, we used a GeCKOv2 genome-wide CRISPR-Cas knock-out library kindly provided by the 155 laboratory of Feng Zhang (41, 42) . The plasmid library contains 122,411 different single guide RNA genes 156 (sgRNA) targeting 19,050 human genes (6 sgRNAs per gene) and 1,864 sgRNA genes targeting miRNA 157 genes (4 sgRNAs per miRNA gene), and includes 1,000 non-targeting (NT) sgRNA genes. Cas9, sgRNA and 158 puromycin-resistance genes are expressed from a single lentiviral vector construct, lentiCRISPRv2. After 159 amplification of the plasmid library and confirmation of its diversity by next generation sequencing (data 160 not shown), a stock of a VSV-G pseudotyped lentiviral vector library was prepared by transient 161 transfection of 293T cells and titrated on the Jurkat reporter cell clones, J-dual#3 and J-dual#6, and 162 parental Jurkat cells. All three cell lines were then transduced with the lentiviral CRISPR-library at an 163 MOI of around 2. Four days after transduction, the 0.01 to 0.02% DsRed positive cells showing the 164 highest BFP expression levels were sorted for next generation sequencing of the sgRNA genes delivered 165 to these cells by the lentiviral vector library. To be able to determine enrichment of sgRNA genes 166 enhancing Gag-BFP expression levels, the representation of each sgRNA gene from non-selected Jurkat 167 cells transduced with the lentiviral CRISPR-library was also determined. Selective enrichment of sgRNA 168 sequences in sorted J-dual#3 and J-dual#6 cells compared to non-sorted Jurkat cells was then 169 determined by MAGeCK, a computational tool developed for the analysis of CRISPR screens (43, 44). The 170 calculated robust ranking aggregation (RRA) score reflects enrichment of sgRNA sequences targeting the 171 same gene in the selected cells. The distribution of the RRA score for all targeted genes is plotted in Fig.  172 2C with the top 12 candidate genes highlighted. For eleven of these, at least two different sgRNA 173 sequences targeting the same gene were enriched in the selected cells arguing against confounding off-174 target effects of single sgRNA (Fig. 2D ). The probability of false discovery of the top 12 candidate genes 175 ranged from 0.0012 to 0.15. 176
177

Analyzing interaction of validated hits shows a network of pre-mRNA splicing factors 178
Based on the enrichment of the individual sgRNAs targeting each of the top 12 candidate genes in the 179 Gag-BFP positive cells selected by flow cytometry (Fig. S1 ), two sgRNA sequences were chosen for each 180 of the candidate genes (Table S1A ) for further validation. Gene-specific sgRNA sequences and a non-181 targeting sequence, named NT1, were cloned individually into the lentiCRISPRv2 vector plasmid. J-182 dual#3 and J-dual#6 reporter cells were then transduced with lentiviral vector particles transferring 183 these sgRNA sequences. Upregulation of BFP expression was observed by flow cytometry for 10 of the 184 12 candidate genes. For nine of them, transfer of both sgRNA sequences upregulated BFP expression in 185 both reporter cell clones ( Fig. S2A ). For DUS2 and ZNF221 the screening results could not be confirmed. 186
Since long half-lifes of mRNAs and proteins may prolong the time from inactivation of the targeted gene 187 to the decline of protein levels, we continued to monitor the reporter cells transduced with sgRNA 188 genes targeting DUS2 and ZNF221 for up to 2 weeks post infection. However, upregulation of Gag-BFP 189 remained undetectable (data not shown). In addition, we confirmed sufficient transduction rates by the 190 lentiviral DUS2 and ZNF221 targeting vectors, excluding the possibility that reduced lentiviral vector 191 titers are responsible for their failure to upregulate BFP expression ( Fig. S2B ). Despite this, the entire 192 screening approach was highly specific showing a false discovery rate of only 0.166. 193
A first hint on potential mechanisms by which inactivation of the identified cellular genes could enhance 194
Gag-BFP expression in the reporter cell lines was obtained by searching for functional protein 195 association networks between the identified genes using the STRING online database (https://string-196 US RNA also lead to decreased ratios of FS over US transcripts (Fig. 4A ). For comparative reasons we also 228 transduced J-dual#3 cells in an independent experiment with a lentiviral vector expressing Rev, sorted 229
Gag-BFP positive cells and quantified HIV-1 US and FS transcripts. Rev enhanced the US HIV-1 RNA levels 230 approximately 5-fold, which coincided with a minor reduction in FS transcripts (Fig. 4A ). 231
The splicing process is closely linked to nuclear mRNA trafficking (54, 55). Therefore, we also determined 232 the effect of targeting the six selected candidate genes on the cytoplasmic levels of HIV-1 US and FS RNA 233 ( Fig. 4B ). Proper separation of the cytoplasm from nuclear components was controlled by examining 234 GAPDH pre-mRNA levels and a nuclear marker protein in the cytoplasmic fraction from Jurkat cells (56, 235 57) . GAPDH pre-mRNA levels per ng total RNA extracted from the cytoplasm were approximately 50-236 fold lower than GAPDH pre-mRNA levels per ng total RNA extracted from whole cells. Consistently, the 237 nuclear LaminB protein could not be detected in the cytoplasmic fractions ( Fig. S4 ). 238
After transduction with the different targeting vectors, HIV-1 US RNA in the cytoplasm of Gag-BFP 239 positive cells was enhanced approximately 22 to 116-fold, while the cytoplasmic FS RNA levels were 240 affected only 0.6 to 2.7-fold. The magnitude of the enhancement of cytoplasmic levels of HIV-1 US RNA 241 exceeded the enhancement of HIV-1 US RNA in whole cell extracts, indicating that knocking-down the 242 selected target genes not only reduced splicing but also enhanced nuclear export of the HIV-1 US RNA. 243
Strong enhancement of cytoplasmic HIV-1-US RNA export was also observed in Rev-expressing cells. 244
However, in contrast to the cells transduced with the targeting vectors, cytoplasmic FS RNA levels in 245
Rev-transduced cells were significantly reduced, consistent with the previously reported suppression of 246 the TAP/NXF1 mediated RNA export by Rev (58). 247
To dissect the relative contributions of inhibition of splicing and enhancement of nuclear export of HIV-1 248 US RNA, we compared the ratio of HIV-1 FS RNA to HIV-1 US RNA in whole cell extracts as a measure of 249 splicing efficiency and the ratio of HIV-1 US RNA in cytoplasmic extracts to the HIV-1 US RNA in whole 250 cell extracts as a measure of nuclear export efficiency. This revealed two different patterns of responses. 251
The fold-reduction of the splicing efficiencies in cells transduced with ISY1, XAB2 and WDR70 targeting 252 vectors mirrored the fold-enhancement of the respective nuclear export efficiencies. Expression of Rev 253 induced a similar pattern of response. In contrast, transduction with DHX38, BUD31 or CRNKL1 targeting 254 vectors predominantly enhanced the nuclear export efficiency with at least three-fold lower effects on 255 splicing efficiency ( Fig. 4C ). In particular, knock-down of CRNKL1 enhanced the ratio of HIV-1 US RNA in 256 cytoplasmic extracts to HIV-1 US RNA in total cell extracts more than 34-fold, while the ratio of HIV-1 FS 257 RNA to HIV-1 US RNA in whole cell extracts was only decreased 4-fold. Targeting of CRNKL1 also led to 258 the strongest enhancement of cytoplasmic levels of HIV-1 US RNAs without reducing cytoplasmic HIV-1 259 FS RNA levels ( Fig. 4C ), indicating that CRNKL1 is a major nuclear retention factor of the genomic HIV-1 260 US RNA. 261
CRNKL1 knock-down shifts cytoplasmic levels HIV-1 splice variants 262
To confirm the role of CRNKL1 in the regulation of cytoplasmic HIV RNA levels and to explore potential 263 effects of CRNKL1 on cytoplasmic levels of cellular RNAs a transcriptomic analysis was performed after a 264 short-term knock-down of CRNKL1. J-dual#3 reporter cells were again transduced with the CRNKL1 265 targeting vector and Gag-BFP-positive cells were sorted by flow cytometry. RNA was extracted from the 266 cytoplasmic fraction of sorted cells and J-dual#3 cells transduced with a control vector. The extracted 267
RNAs from 4 biological replicates each were then enriched for mRNAs and sequenced by the Illumina 268
High-seq procedure. In addition to this, cytoplasmic mRNA was extracted from J-dual#3 cells expressing 269
Gag-BFP after transduction with the Rev-encoding lentiviral vector and sequenced. 270
To confirm the effectiveness of Cas9/sgRNA-mediated knock-down by transcriptomic analysis, a core 271 target region in exon 3 of the CRNKL1 gene was defined as nucleotides -3 to +3 relative to the SpCas9 272 cleavage site. The number of RNA-seq reads that contained 10 nucleotides upstream and downstream 273 of the core target region were then determined ( Fig. S5 ). While 55 reads on average mapped to the 274 region flanking the core target region in the control cells, only a mean of 5.8 reads were detected in cells 275 transduced with the CRNKL1 knock-down vector ( Fig. S5 ). Larger deletions and substitutions outside the 276 core target region probably reduce the number of reads that can be mapped to the flanking region. 277
Comparison of the reads from CRNKL1 knock-down cells that can be mapped to the flanking region with 278 the wild type CRNKL1 core target region revealed insertions, deletions and point mutations in 22 out of 279 23 reads. In control cells, only 2 out of 219 reads contained single point mutations clearly indicating 280 efficient inhibition of CRNKL1 expression after Cas9/sgRNA targeting ( Fig. S5) . 281 HIV reads were mapped to the proviral DNA of HIV-dual-GT revealing more reads mapping to intronic 282 regions after CRNKL1 knock-down and Rev expression than in the controls (Fig. 5A ). The percentage of 283 reads mapping to HIV among all the reads uniquely mapping to either the human or the viral genome 284 (total uniquely mapped reads) was enhanced two fold in CRNKL1 knock-down cells (Fig. 5B ). This was 285 not due to an enhanced transcriptional activity since the percentage of reads mapping to Exon 1, which 286 is shared by all HIV transcripts, was only affected marginally( Fig. 5C ). Changes in HIV-1 US RNA were 287 assessed by determining the percentage of reads mapping to the first intron of HIV-1 between SD1-SA1 288 (5D) or mapping to the unspliced SD1 site (5E) revealing 4 and 12-fold increases under CRNKL1 knock-289 down conditions, respectively. The percentage of reads mapping to the unspliced SD4 site and therefore 290 containing the env intron also increased by a factor of 9 ( Fig. 5F ). The change in the percentage of all 291 spliced HIV reads was negligible ( Fig. 5G ) indicating that knock-down of CRNKL1 does not reduce splicing 292 of HIV RNAs in general. 293
To further explore differences in cytoplasmic levels of differentially spliced HIV-1 transcripts the precise 294 splice site usage was also systematically analyzed by calculating the percentage of reads covering 295 specific SD-SA pairs among all spliced HIV reads ( Fig. S6A,B ). This revealed that knock-down of CRNKL1 296 reduced cytoplasmic HIV transcripts spliced from SD1 to SA1 approximately two-fold, while transcripts 297 spliced from SD1 to SA3 were enhanced three-fold ( Fig. 5H ). To further assess the effect of the CRNKL1 298 knock-down on the major Env encoding transcript, the percentage of reads spliced to SA5 was 299 determined ( Fig. 5I ). Independent of the SD sites, usage of SA5 trended to be reduced, which is similar 300 to an effect recently reported for the splicing factor DDX17 (59). Moreover, the level of fully spliced 301 transcripts seemed unaffected by the CRNKL1 knock-down since the percentages of reads spliced either 302 from SD1 to any splice acceptor site or from SD4 to SA7 were nearly the same (Fig. 5J ). 303 304 CRNKL1 is a regulator of cytoplasmic cellular mRNA levels 305
The influence of the CRNKL1 knock-down on cytoplasmic mRNA levels was also determined ( Fig. S7A,B ). 306
To display the results the log2-transformed expression differences were plotted against the expression 307 level for each gene in a MA-plot ( Fig. 6A ). To reduce noise and arbitrarily large fold changes from low 308 expressed genes the log2 fold changes are shrunk putting less weight on low expressing genes. 309
Significant differences after correction for multiple testing revealed the upregulation of 1249 and 310 downregulation of 2569 mRNAs, respectively. Two hundred and ten mRNAs even showed a more than 311 4-fold (log2 fold change >2) increase after knock down of CRNKL1. Interestingly, upregulated mRNAs 312 were enriched for the functional categories involved in transcription ( Fig. 6B ) while downregulated 313 mRNAs were more frequently associated with functions in cell cycle and organelle organization ( Fig. 6B ). 314
Given the close link between RNA export and splicing, a more general role of CRNKL1 on cytoplasmic 315 levels of splice variants was analyzed upon CRNKL1 knock-down. Individual splicing events (including 316 skipped exons, alternative splice sites and retained introns) were quantified using the percent spliced-in 317 metric (PSI, Schafer et al., 2015) and differential analysis was carried out by SUPPA (61). Of all quantified 318 splicing events in cytoplasmic mRNAs upon CRNKL1 depletion, 2.4 % were upregulated and 1.6% 319 downregulated ( Fig. S7C,D) . Introns were more frequently retained upon CRNKL1 depletion compared to 320 wild-type cells ( Fig. 6C ). Similarly, alternative 3' and 5' splice sites were more frequently detected upon 321 CRNKL1 knock-down, suggesting that CRNKL1 inhibits usage of alternative splice sites ( Fig. 6C) . 322 A total of 295 introns were more frequently retained in cytoplasmic mRNAs after CRNKL1 knock-down. 323
Further analyses revealed that not all introns of the same transcript were affected in the same way ( Fig.  324 S8), but rather that intron retention was highly specific for one or a few introns of the same gene. 325
Enhanced cytoplasmic levels of intron-retaining mRNAs could be confirmed by real-time PCR with 326 primers spanning the respective exon -intron junctions (Fig. S8 ). 327
Genes containing introns or alternative splice sites that were upregulated after CRNKL1 knock-down 328
were not enriched for particular functional categories (data not shown). Enhanced detection of introns 329 or alternative splice sites in cytoplasmic mRNAs after CRNKL1 knock-down indicates that CRNKL1 330 suppresses either these splicing events or the nuclear export of the respective splice variants. To gain 331 insight into the principles of regulation of these CRNKL1 knock-down dependent introns and alternative 332 splice sites, we analyzed common features of these splicing events, including splice site strength, branch 333 point and polypyrimidine tract score, GC content and intron length. CRNKL1 knock-down-dependent 334 alternative 3' splice sites showed significantly lower branch point scores than constitutive 3' splice sites 335 ( Fig. 6D ), but a similar length of polypyrimidine tracts ( Fig. S7E ). We also found that CRNKL1-dependent 336 introns were significantly longer than CRNKL1-independent introns within the same transcript ( Using a genome-wide screen for cellular factors repressing expression of an HIV-1 structural protein 342 from the unspliced RNA, we identified ten target proteins linked to mRNA metabolism, with nine of 343 them associated with the spliceosome. Interestingly, five of them (ISY1, BUD31, XAB2, CRNKL1 and 344 CWC22) are found in the Prp19-associated complex. This complex is important for stabilizing the 345 spliceosome, which is also involved in DNA repair, transcriptional elongation, and RNA export (51). Given 346 that the yeast homolog of WDR70 was reported to interact with Prp19 (62) and is now shown to affect 347 RNA splicing, it could be a new member of the Prp19-associated complex. Due to the close linkage of 348 splicing with RNA stability and nuclear RNA export, it is difficult to disect the precise mechanism by 349 which deletion of the identified nuclear proteins enhance cytoplasmic RNA levels of HIV-1-US RNA. 350
Theoretically, enhanced transcription, reduced nuclear or cytoplasmic degradation, decreased splicing, 351 and/or enhanced nuclear export can increase cytoplasmic levels of HIV-1 US RNA (US cyt. ) ( Fig. 7) . 352
Enhanced transcription and decreased nuclear degradation seem unlikely since the percentage of reads 353 mapping to the first HIV-1 Exon present on all viral transcripts was not significantly enhanced ( Fig. 5B ). 354
The absence of enhanced cytoplasmic levels of FS RNAs and DsRed expression levels from the dual 355 reporter construct ( Fig. 4B, Fig. S2A ) also argues against such a mechanism. Assuming a single pool of 356 nuclear HIV-1 US RNA that could follow either of the two remaining pathways, differential effects on the 357 nuclear export efficiency (US cyt. /US whole ) and splicing efficacy (FS whole /US whole ) are expected ( Fig. 7) . 358
Enhancing nuclear export of HIV-1 US RNA should strongly enhance the ratio of US cyt. /US whole . Since rapid 359 export may reduce splicing and degradation, the ratio of FS whole /US whole may responsively decrease, 360 although to a lower extent. Reduced splicing should primarily decrease the ratio of FS whole /US whole , but 361 not the ratio of US cyt. /US whole (Fig. 7 ). Similar to an enhanced nuclear export, reduced degradation of 362 cytoplasmic HIV-1 US RNA should also lead to enhanced US cyt. /US whole and decreased FS whole /US whole ratios 363 ( Fig. 7) , but the association of the identified proteins with the spliceosome localized in the nucleus 364 argues against such a cytoplasmic effector mechanism. 365 Clearly, ablation of all 6 target genes tested reduced the splicing efficacy (FS whole /US whole ) indicating that 366 the targeted genes are enrolled in splicing and/or nuclear retention. The relative contribution of 367 reduced splicing versus enhanced nuclear export of the HIV-1 US RNA differed between the different 368 target genes. The XAB2 knock-down decreased the splicing efficacy 12.5-fold and the nuclear export 369 efficacy of the HIV-1 US RNA 11.7-fold. Since splicing and nuclear export efficacy were affected to a 370 similar degree, it is not possible to conclude whether XAB2 predominantly acts as a splicing or nuclear 371 retention factor. This is consistent with previous observations that depleting splicing factors (e.g. SF1, 372 U2AF65 and Prp19) can cause pre-mRNA leakage into the cytoplasm (30, 63-65). In contrast to the 373 effect of the XAB2 knock-down, the splicing efficacy after knock-down of CRNKL1 is only decreased 4.0-374 fold, while the nuclear export efficiency based of the HIV-1 US RNA increases 34.6-fold. Since the ratio of 375 HIV-1 FS to US transcripts in the cytoplasmic RNA is also reduced to a larger extent than in the whole cell 376 RNA, enhanced nuclear export of the HIV US RNA after inactivation of the target gene seems to play a 377 dominant role. This indicates that CRNKL1 is primarily required for retention of the HIV-1 US RNA in the 378 nucleus and not for its splicing. The precise molecular mechanism by which the CRNKL1 knock-down 379 leads to a more than 100-fold enhancement of cytoplasmic HIV US RNA levels remains to be clarified. 380 CRNKL1 has been previously reported to regulate splicing and assist the export of cellular intron-less 381 mRNAs in cooperation with the TREX (TRanscription-EXport) complex, U2AF65 and other NTC members 382 (66-68). Our observation that targeting of CRNKL1 did not enhance cytoplasmic levels of HIV-1 FS RNA, 383 which uses the default TAP/NXF1 export pathway, indicates that CRNKL1 is not a global nuclear mRNA 384 retention factor. Our transcriptomic analysis also indicates a highly selective differential regulation of 385 cytoplasmic levels of HIV-1 splice variants. The only spliced HIV-1 transcripts that were clearly 386 upregulated by CRNKL1 knock-down have spliced SD1 to the SA3 site ( The transcriptomic analyses after CRNKL1 knock-down also revealed a selective regulation of 392 cytoplasmic levels of cellular mRNAs. We found that 11.0% and 20.1% of expressed mRNAs in the 393 cytoplasm were up-and downregulated, respectively. Functionally, the upregulated mRNAs are 394 associated with transcription, while downregulated mRNAs are more frequently associated with the cell 395 cycle and organelle organization suggesting that CRNKL1 participates as a master regulator in these 396 cellular programs. Since altered nuclear export after CRNKL1 depletion could result in differences in the 397 abundance of different cytoplasmic mRNA isoforms, we investigated alternatively spliced cytoplasmic 398 isoforms upon CRNKL1 knock-down. Upon CRNKL1 depletion a much higher number of included introns 399 and alternative 3' and 5' splice sites than the excluded ones were detected, suggesting that CRNKL1 400 promotes splicing of these events or highly selective nuclear retention. Intron retention in the absence 401 of CRNKL1 was highly restricted and even varied among introns of the same gene ( Fig. S8 ). Searching for 402 common properties of introns that were retained revealed that their mean length was significantly 403 greater compared to introns with unchanged inclusion upon CRNKL1 depletion. In addition, usage of 3' 404 splice sites with lower branch point scores seems to be blocked in the presence of CRNKL1. Therefore, 405 the sequence features of CRNKL1-dependent splicing events seem to reside at the 3' rather than at the 406 5' end of the intron. 407
Mechanistically, one plausible hypothesis based on the nuclear retention observed for the HIV-1 408 unspliced RNA is that a nuclear RNP complex binds in a CRNKL1 dependent manner to RNA motifs 409 present in a highly selective subset of cellular and viral introns leading to their nuclear retention and 410 splicing. CRNKL1 dependent binding to binding motives on cellular transcripts leading to nuclear 411 retention and degradation may also explain the increase in cytoplasmic levels of cellular mRNAs upon 412 CRNKL1 knock-down. 413
In summary, our study identifies three spliceosomal proteins that are required for nuclear retention of 414 the HIV-1 unspliced RNA and indicates that CRNKL1-dependent nuclear retention is a novel mechanism 415 for the regulation of cytoplasmic levels of intron-retaining cellular mRNAs that is hijacked by HIV-1. 416 417
Materials and Methods 418
Plasmids Plasmids expressing viral proteins, HIV-1 Rev (pcRev), HIV-1 Tat (pcTat), HIV-1 codon-419 optimized Gag-Pol (Hgp syn ) and VSV-G (pHiT-G) were described previously (23, 56). Lentiviral packaging 420 plasmid pPAX2 and pMD2.G were obtained from Addgene (#12260 and #12259). HIV-1 proviral plasmid 421
HIV∆e is based on the HIV-1 molecular clone NL4-3 and contains a 4-nucleotide deletion at its NheI site 422 leading to inactivation of env. The plasmid HIV∆r-e contains an additional mutation of the start codon of 423 rev and a premature stop codon in the first rev exon (57). 424 Proviral reporter plasmid HIV-dual-GT was constructed based on HIV∆r-e. A cassette containing 425 mTagBFP2, a PEST coding sequence (destabilized BFP) and two stop codons were ligated in frame to the 426 3' end of gag, forming a new ORF for Gag-BFP. The Slippery Sequence TTTTTTA (nt 2085 to nt 2091 of 427 the GenBank entry AF324493.2) was mutated to CTTCCTG to prevent Gag-Pol translation (69). The 428 coding sequence of Nef close to its 5´end (nt 8796 to nt 8880 of the GenBank entry AF324493.2) was 429 replaced by a cassette consisting of a 3 x Ala linker sequence and the DsRed max coding region followed 430 by two stop codons. The sequence (nt 5131 to nt 6297 of the GenBank entry AF324493.2) ranging from 431 vif to vpu was replaced by the corresponding region of NL4-3-∆6-drEGFP (70) harboring inactivating 432 point mutations in vif, vpr and vpu. The rev ORF was inactivated as described above for HIV∆r-e by PCR 433 mutagenesis. The plasmid HIV-dual-GT including the final sequence is available from AddGene (plasmid 434 ID 122696). Individual CRISPR knock-out plasmids were constructed based on lentiCRISPRv2 (#52961, 435 Addgene) and GeCKOv2 sgRNA target sequences. All sgRNA sequences of the GeCKO v2 library can be 436 found at www.addgene.org/pooled-library/zhang-human-gecko-v2/. The different sgRNA sequences 437 selected for validation are provided in Supplementary Table S1A . Each of the sgRNA sequences were 438 cloned into the vector following the instructions on the Addgene webpage (www.addgene.org/52961/). The transfection efficiency after expression of a GFP reporter plasmid was estimated to be between 10% 466 -20%. 467
Western blot analyses Immunoblotting for HIV-1 Gag/CA p24 was described previously (57). 468
Immunoblotting for Rev was performed with primary antibody Sheep Anti-Rev (1:4,500, #H6006, US 469 Biological Life Sciences) and secondary antibody Rabbit Anti-Goat Ig/HRP (1:5,000, #P0160, Dako). 470
Immunoblotting for α-Tubulin was performed using polyclonal Rabbit Anti-α-Tubulin antiserum as 471 primary antibody (1:4,000, #600-401-880, Rockland), and Swine Anti-Rabbit Ig/HRP (1:5,000, #P0217, 472 Dako) as secondary antibody. In the experiment of Figure 1B , anti-α-Tubulin blotting was conducted 473 after stripping the blotted anti-CA membrane by stripping buffer (#2504, Millipore). The membrane was 474 then re-blocked, and subsequently re-blotted with antibodies as described above. Immunoblotting for 475
LaminB was performed with primary antibody Goat anti-LaminB (C-20) (1:500, #sc-6216, Santa Cruz 476 Biotechnology) and secondary antibody Rabbit anti-goat Ig HRP (1:5,000, #P0160, Dako). 477 Jurkat, J-dual#3 and J-dual#6 cells were infected with the lentiviral vectors or the lentiviral vector library 488 by spinoculation. 1.5 million of cells were centrifuged with 1 ml vector preparation, in the presence of 8 489 μg/ml polybrene (Sigma-Aldrich), at 2,000 rpm, for 3 h, at 33℃. After spinoculation, the supernatants 490 were removed and the cells were continued to be cultured. 491 VSV-G-pseudotyped HIV∆e, HIV∆r-e and HIV-dual-GT vector particles were titrated on TZM-bl cells as 492 previously described (57). The titers were 5.8x10 6 and 5.1x10 6 TU/ml for two independent titrations of 493 HIV∆e, 4.3x10 6 and 5.7x10 6 TU/ml for two independent titrations of HIV∆r-e and 6.4x10 5 and 5. (dilution factor). The highest value resulting from these dilutions was taken as vector titer on Jurkat cells. 500
Lentiviral vector preparation, infection and titration
The determined titers for two independent titrations of HIV-dual-GT were 4.9x10 5 and 6.9x10 5 TU/ml. 501
The individual CRISPR-KO vectors, as well as the GeCKO v2 lentiviral vector library, were titrated on J-502 dual reporter cells and parental Jurkat cells. The cells infected by the serially diluted virus were grown 503 for 24 h, afterwards divided into two equal aliquots. One aliquot was then cultured in 2 µg/ml 504 puromycin, the other without puromycin. After 30 h of growth, viable cells were counted by trypan blue 505 staining. The transduction percentage was calculated in the following way: (number of living cells in 506 treated population) x100/ (number of living cells in untreated population). For the GeCKO v2 lentiviral 507 vector library the transduction percentage was multiplied by the number of cells exposed to calculate 508 the titer for the different dilutions of the library. The highest value obtained from the different dilutions 509 of the same batch of the lentiviral vector library was taken as its titer. The titers were 1.3x10 7 TU/ml for 510 the first batch and 2.2x10 6 TU/ml for the second batch. 511 Reverse-transcription PCRs (RT-qPCR) for quantification of HIV-1 US, FS RNAs and cellular GAPDH pre-543 mRNAs were done with the QuantiTect SYBR Green RT-PCR Kit (Qiagen), and performed essentially as 544 described previously (56, 78). Using the applied Biosystems 7500 Real-Time PCR machine cycling 545 conditions were as follows: HIV-1 US RNA: 95℃ 10 sec for denaturation, 65℃ 60 sec for annealing, 72℃ 546 30 sec for elongation and fluorescence detection; for HIV-1 FS RNA: 95℃ 10 sec for denaturation, 64℃ 547 15 sec for annealing, 72℃ 15 sec for elongation, and 81℃ 30 sec for fluorescence detection. 548 RT-qPCRs for relative quantification of Intron 6-retaining RPL10 mRNAs and Intron 1-retaining C19orf53 549 mRNAs were done with primers illustrated in Table S1D . Cycling conditions for both: 95℃ 10 sec for 550 denaturation, 50℃ 60 sec for annealing, 72℃ 60 sec for elongation and fluorescence detection. 551
Calculation of the ratios of HIV FS and US RNA levels and fold changes
To measure the effect of 552 candidate genes and Rev on RNA splicing efficacy, we first determined the ratio between FS whole :US whole 553 by dividing the FS copy numbers/ng extracted RNA by the US copy numbers/ng extracted RNA for each 554 sample of each treatment group (knock-down or +Rev) and then calculated the mean of the ratios of 555 replicates of each treatment group. The mean of the ratios of each treatment group were then divided 556 by the mean of the ratios observed in matched control cells transduced with the NT1 or the GFP-557 expression vector to calculate the fold changes given in Table 2 . 558
To measure the effect of candidate genes and Rev on the nuclear export efficacy (35) for HIV-1 US RNA 559 for each treatment group, the mean US copy numbers/ng RNA extracted from the replicates of the 560 cytoplasmic fractions were divided by the mean US copy numbers/ng RNA extracted from replicates of 561 the whole cell lysates. The ratio of each treatment group were then again divided by the ratios observed 562 in controls cells transduced with the NT1 or the GFP-expression vector to calculate the fold changes 563 given in Table 2 . 564
Fold changes for cytoplasmic levels of US or FS RNA were calculated by dividing the mean US or FS copy 565 numbers per ng of extracted RNA of each treatment group by the mean derived from the control groups. 566
RNA-seq Cytoplasmic RNAs were extracted from the sorted BFP+ or unsorted control J-dual#3 cells 567 with the Direct-zol RNA miniprep plus kit. RNA qualities were controlled by the 2100 Bioanalyzer 568 instrument (Agilent) (data not shown). For each sample, a DNA fragment library was generated from the 569 total RNA input using the Illumina TrueSeq Stranded mRNA kit and performed essentially as described 570 by the manufacturer's protocol (https://support.illumina.com/downloads/truseq-stranded-mrna-571 reference-guide-1000000040498.html). The libraries were sequenced on an Illumina HiSeq 2500 572 platform and the reads were saved together with a quality score. Raw data were converted to reads 573 including a quality score by Software bcl2fastq v2.17. Sequences matching Illumina TrueSeq adapters 574 were masked. Low quality bases, poly-A or poly-T stretches as well as masked bases were trimmed by 575 Software fqtrim v0.9.5. Read quality was checked after sequencing and after base trimming by Software 576 fastqc v0.11.8. For the viral genome, reads were aligned to HIV-Dual-GT using hisat2 (79). Read counting 577 for the different features was performed using samtools (80) and regtools (81). 578 For splicing and differential expression analysis, reads were aligned to the human transcriptome using 579 RSEM v1.2.20 (82) and Bowtie v1.1.2 (82) as read alignment program using default parameters. 580 Differential expression analysis was performed by DESeq2 v1.18.1 (82) using the RSEM output for read 581 counts per gene. We considered genes that showed an absolute log2-transformed fold change greater 582 than 1 and a Padj value of less than 0.1 as differentially expressed. To exclude lowly expressed genes, we 583 only considered those with mean TPM greater than 1 in either untreated or knockdown samples. 584
Gencode v19 annotation was used in all steps of the analysis, including in the definition of protein 585 coding genes. The reads mapping profiles were exhibited via the Integrative Genomics Viewer (IGV) v2.3 586 (83). Differential splicing analysis was performed with SUPPA (61) using TPM values from the RSEM 587 transcript isoform output. For PSI calculation, events were required to pass the expression filter of TPM 588 greater than 1 (-f 1 parameter). We considered splicing events with Padj values lower than 0.01 and 589 absolute ∆PSI greater than 0.25 as differentially included or excluded. Polypyrimidine track length, and 590 branch point scores were calculated using BPfinder (84). Splice-site strength was calculated using 591
MaxENT (85) (hollywood.mit.edu/burgelab/software.html). 592
Data availability 593
The raw and processed data of RNA-seq are accessible via the GEO (Gene Expression Omnibus) 594 Accession Number GSE144347. 
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The authors declare that they have no competing interests. 607 protein-protein interactions for the most enriched pathway, the "mRNA splicing" pathway (pathway ID: 833 GO 0000398; false discovery rate: 5.07e-14; minimum required interaction score: 0.400 (medium 834 confidence)). 835 control cells were prepared as described in (A), but total RNA was extracted from the cytoplasmic 846 fraction of each cell sample. Log copies per ng total cytoplasmic RNA and mean ratios of FS cyt. /US cyt. were 847 calculated and presented as in (A). (C) The fold changes in the different treatment groups for the splicing 848 efficacy (FS whole /US whole ), the nuclear export efficacy (US cyt. /US whole ), and cytoplasmic levels of unspliced 849 (US cyt. ) and fully spliced (FS cyt. ) transcriptes were calculated by dividing the values in the treatment 850 groups by the ones obtained from the matched control cells (NT1, GFP) as described in the Materials 851
Figure legends
and Methods. Paired t-test was performed on the log copy numbers/ng total RNA between each of the 852 treatment groups and the matched control. * p<0.05, ** p<0.01, ***p<0.001. Unless otherwise 853 indicated, differences were not significant. Dotted lines separate experiments that were not performed 854 in parallel and therefore contain independent controls. WDR70.KD cells were sorted on day 7 after 855 transduction, while other cells were sorted on day 4. 856 vector particles under the same conditions. The same volume of individual lentiCRISPR vector 908 preparation was used to infect J-dual#3 cells. The percent transduction was calculated as described in 909
Materials and Methods. 910 Polypyrimidine track length was obtained by BPfinder for retained introns with higher inclusion upon KD 948 (CRNKL1-dependent) and compared to that of unchanged retained introns upon KD (CRNKL1-949 independent), which were located in the same transcripts as CRNKL1-dependent ones. Box plots and 950 data points are shown. Wilcoxon rank sum test was used to test for significance. Absolute numbers of 951 retained introns in both groups are indicated. (G) GC content of retained introns with higher inclusion 952 upon KD (CRNKL1-dependent) was compared to the GC content of unchanged introns upon KD (CRNKL1-953 independent), which were located in the same transcripts as CRNKL1-dependent ones. Box plots and 954 data points are shown. Wilcoxon rank sum test was used to test for significance. Absolute numbers of 955 retained introns in both groups are indicated. 956
Figure S8. Examples and validation of intron retention in cellular transcripts after CRNKL1 knock-down. 957
Mapping of the reads to genes with enhanced intron retention (RPL10, C19orf53 CD320), an alternative 958 5´and 3´splice site usage (5 th intron of AURKB) and an unaffected gene (EIF6) are shown for the four 959
replicates of control (NT1) and CRNKL1 knock-down cells and the rev expressing cells. For RPL10 and 960
C19orf53, intron retention was confirmed by RT-qPCR. Binding sites for specific primers spanning the 961 exon-intron junctions are indicated by green arrows. RT-qPCRs were performed for relative 962 quantification of respective intron-retaining transcripts using the cytoplasmic RNAs from the RNA-seq 963 experiment. ∆CT(NT1-KD) ±SEM values obtained from the 4 replicates are indicated. 964 
